On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...